Researchers receive $2.5 million award to develop a tailored treatment for glioblastoma

A multidisciplinary team of investigators from the UCLA Jonsson Comprehensive Cancer Center was awarded a $2.5 million Translational Team Science Award from the Department of Defense to develop a tailored treatment for glioblastoma, a deadly brain tumor with limited treatment options.

FDA approves Takeda’s colorectal cancer drug Fruzaqla – Pharmaceutical Technology

The drug is already approved in China and is also currently under review for marketing authorisation by the European Medicines Agency (EMA). Image credit: Shutterstock/Tada

November 9, 2023

Researchers identify the role of iron in ocular toxoplasmosis

Researchers from Nagoya University Graduate School of Medicine have identified the role of iron in ocular toxoplasmosis (OT), a form of toxoplasmosis that causes blindness.

November 15, 2023

Minocycline fails to slow vision loss in people with dry age-related macular degeneration

The drug minocycline, an antibiotic that also decreases inflammation, failed to slow vision loss or expansion of geographic atrophy in people with dry age-related macular

March 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.